Tocris in the News
View the latest Tocris Bioscience news
2012 Articles
Tocris US Office Transition
4th Jan 2012
Information regarding the transition of Tocris' US Office to R&D Systems in Minneapolis.
2011 Articles
Tocris Bioscience Joins R&D Systems
4th May 2011
We are pleased to announce that Tocris Bioscience is combining with R&D Systems.
2010 Articles
Tocris Signs Deal to Supply Pfizer Research Compounds
15th March 2010
Tocris announces an agreement with Pfizer which will result in a wide range of Pfizer compounds being made available to the global research community.
Tocris Extends Range of Light-Sensitive Caged Compounds
1st March 2010
Tocris expands their license agreement with Columbia University to include RuBi-Glutamate and RuBi-4AP.
2009 Articles
Tocris Bioscience Awards Prize for Pharmacology Research
25th July 2009
Chris Williams and Shaista Nisar, both PhD students at the University of Bristol, were selected as the best pharmacology research students of their year.
Tocris Launches New and Improved Website
16th June 2009
www.tocris.com is now powered by a faster and more efficient search engine that allows users to pinpoint the most relevant research tools in seconds!
Tocris Launches Novel Light-sensitive Caged GABA Compound
27th April 2009
We are the first to launch novel light-sensitive caged GABA compound: RuBi-GABA licensed from Columbia University.
Tocris Launches New 2009-2010 Life Science Catalog
31st March 2009
Our new catalog is packed-full of cutting edge products, from the very latest research tools through to established biochemical standards.
Tocris Signs Exclusive Deal to Supply Anastrozole & Bicalutamide
26th February 2009
For the first time, scientists will be able to buy fully licensed, non-formulated anastrozole and bicalutamide as off-the shelf products.
Tocrifluor T1117: The First Fluorescent Cannabinoid Ligand
25th February 2009
Exclusively available from Tocris Bioscience, Tocrifluor T1117 is the first fluorescent cannabinoid ligand commercially available.
2008 Articles
A Novel Range of Conotoxins to Boost Neurological Research
28th November 2008
Tocris announces a new range of conotoxins which includes some of the most potent and diverse neurotoxins known.
Tocris Bioscience Sponsors University of Bristol Football Team
20th October 2008
Tocris Bioscience announces official sponsorship of The University of Bristol Physiology and Pharmacology football team.
Exciting New Link Between Human Genes & Reagents from Tocris
22nd September 2008
GeneCards, the world leading online database of genes, directly links to relevant and cutting edge research reagents from Tocris Bioscience.
Tocris Signs Exclusive Deal to Supply Gefitinib for Cancer Research
4th September 2008
For the first time, scientists will be able to buy fully licensed, non-formulated Gefitinib (Iressa™) as an off-the shelf research product.
Target Detective Connects Biological Targets to Molecules
27th August 2008
Tocris Bioscience announces the official launch of Target Detective, a search facility that connects biological targets to research molecules.
Tocris Bioscience Awards Prize for Pharmacological Research
5th August 2008
Sam Goodchild was selected as the best pharmacology research student of his year, winning a cash prize and a certificate from Tocris.
For media enquiries or to arrange an interview:
Contact: Adele Sheehan
Telephone: +44 (0)117 916 3343
Email:
Archived News Articles
2007
- Tocris Bioscience Launches New Unique & Affordable Screening Library
- Tocris Bioscience Launches Custom Synthesis Business
- Tocris Bioscience Awards Prize for Pharmacological Research
- Tocris Bioscience Completes Management Buy Out
2006
- Tocris Bioscience Announces the Re-availability of Research Grade Ryanodine
- Tocris Bioscience Receives Multiple Nominations in Prestigious Life Science Industry Awards
2005
Quick Order
Find multiple products by catalog number
New Product E-alerts
Sign up for monthly new product e-alerts
RSS News Feed
Find out about new products as soon as they go live!
Click on the orange RSS button to read more about our RSS feed and actively opt in.

